Synthetic biology opens doors to vaccines, cell reporting

05/15/2013 | MIT Technology Review online

Synthetic biology holds the promise of quicker responses to flu emergencies and even cell-based computing. Novartis has developed a way to synthesize virus genomes chemically, then grow them in tissue cultures, greatly speeding vaccine production. Work at Harvard University has shown that logic gates can be fashioned from engineered proteins, opening the way for possible application in reporting on cell experiences in bodies.

View Full Article in:

MIT Technology Review online

Published in Brief: